# Wen-Hung Chen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/wen-hung-chen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 30 |
| Field | Rheumatoid Arthritis Research and Therapies |
| h-index | 3 |
| i10-index | 1 |
| Last Known Institution | GlaxoSmithKline (United States) |
| OpenAlex ID | https://openalex.org/A5016569908 |
| ORCID iD | 0000-0002-6610-9709 |
| Works | 10 |

## Researcher papers

- [Validation of the PROFAD-SSI-SF in Patients with Primary Sjögren's Syndrome with Organ Involvement: Results of Qualitative Interviews and Psychometric Analyses](https://scholariq.org/papers/validation-of-the-profad-ssi-sf-in-patients-with-primary-sjogren-s-syndrome-with/)
- [Meaningful score changes for SF-36v2, FACIT-fatigue, and RASIQ in rheumatoid arthritis](https://scholariq.org/papers/meaningful-score-changes-for-sf-36v2-facit-fatigue-and-rasiq-in-rheumatoid/)
- [A concept elicitation study to understand the relationship between sleep and pain in rheumatoid arthritis and axial spondyloarthritis](https://scholariq.org/papers/a-concept-elicitation-study-to-understand-the-relationship-between-sleep-and/)
- [SF-36v2 and FACIT-Fatigue quality of life improvements with organ-specific SELENA-SLEDAI response and belimumab treatment in patients with systemic lupus erythematosus](https://scholariq.org/papers/sf-36v2-and-facit-fatigue-quality-of-life-improvements-with-organ-specific/)
- [Patient-reported outcome measures for lupus nephritis: content validity of LupusQoL and FACIT-Fatigue](https://scholariq.org/papers/patient-reported-outcome-measures-for-lupus-nephritis-content-validity-of/)
- [Development of a Conceptual Model to Understand Disease Burden in Patients With Systemic Lupus Erythematosus and Organ Damage](https://scholariq.org/papers/development-of-a-conceptual-model-to-understand-disease-burden-in-patients-with-2/)
- [Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study](https://scholariq.org/papers/safety-and-tolerability-of-intramuscular-sotrovimab-administered-at-different/)
- [Clinical Features and Outcome in Myasthenia Gravis Patients with Antimuscle-specific Tyrosine Kinase Antibody: A Retrospective Study](https://scholariq.org/papers/clinical-features-and-outcome-in-myasthenia-gravis-patients-with-antimuscle/)
- [LSO-068 Association between organ-specific safety of estrogens in lupus erythematosus national assessment-systemic lupus erythematosus (SLE) disease activity index (SELENA-SLEDAI) response to belimumab and SF-36v2 and FACIT-fatigue scores in patients with SLE](https://scholariq.org/papers/lso-068-association-between-organ-specific-safety-of-estrogens-in-lupus/)
- [Development of a Conceptual Model to Understand Disease Burden in Patients With Systemic Lupus Erythematosus and Organ Damage](https://scholariq.org/papers/development-of-a-conceptual-model-to-understand-disease-burden-in-patients-with/)

## Researcher topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Osteoarthritis Treatment and Mechanisms](https://scholariq.org/topics/osteoarthritis-treatment-and-mechanisms/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Atherosclerosis and Cardiovascular Diseases](https://scholariq.org/topics/atherosclerosis-and-cardiovascular-diseases/)

## Researcher university

- [GlaxoSmithKline (United States)](https://scholariq.org/institutions/glaxosmithkline-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.